transfection mixture Search Results


dna-transfection reagent mixture  (Corning Life Sciences)
90
Corning Life Sciences dna-transfection reagent mixture
Dna Transfection Reagent Mixture, supplied by Corning Life Sciences, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/dna-transfection reagent mixture/product/Corning Life Sciences
Average 90 stars, based on 1 article reviews
dna-transfection reagent mixture - by Bioz Stars, 2026-05
90/100 stars
  Buy from Supplier
sirnas mixture  (Viromer Transfection)
90
Viromer Transfection sirnas mixture
Sirnas Mixture, supplied by Viromer Transfection, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/sirnas mixture/product/Viromer Transfection
Average 90 stars, based on 1 article reviews
sirnas mixture - by Bioz Stars, 2026-05
90/100 stars
  Buy from Supplier
x-tremegene dna transfection mix  (Merck & Co)
90
Merck & Co x-tremegene dna transfection mix
X Tremegene Dna Transfection Mix, supplied by Merck & Co, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/x-tremegene dna transfection mix/product/Merck & Co
Average 90 stars, based on 1 article reviews
x-tremegene dna transfection mix - by Bioz Stars, 2026-05
90/100 stars
  Buy from Supplier
transfection mixture  (Infors AG)
90
Infors AG transfection mixture
Transfection Mixture, supplied by Infors AG, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/transfection mixture/product/Infors AG
Average 90 stars, based on 1 article reviews
transfection mixture - by Bioz Stars, 2026-05
90/100 stars
  Buy from Supplier
transfection mixture  (Jackson Laboratory)
90
Jackson Laboratory transfection mixture
Endothelial differentiation of the human Isl1 + progenitors can be achieved by repeated transfections of the VEGF-A modRNA. (A) FACS result showing expression of mCherry in the day-7 purified human Isl1-cre eGFP + cells 24 h post <t>transfection</t> of the mCherry modRNA (1 μg/10 6 cells). (B) Quantification of mCherry expression by FACS showing percentage of mCherry + Isl1-cre eGFP + cells following 0-150 h post transfection. (C) ELISA analyses using VEGF-A-containing supernatant (refreshed 6 h before collection) cultured with the day-7 purified human Isl1-cre eGFP + cells following 0-72 h post transfection of different concentrations of the VEGF-A modRNA. (D) Trypan blue staining showing the survival percentage of the day-7 purified human Isl1-cre eGFP + cells following 24 h post transfection of different concentrations of the VEGF-A modRNA. (E) ELISA analyses showing the rate of VEGF-A secreted by the day-7 purified human Isl1-cre eGFP + cells (supernatant refreshed 6 h before collection) following two rounds of daily transfections of 1 μg/10 6 cells with VEGF-A modRNA. (F) FACS analyses showing the efficiency of CD144 + CD31 + EC differentiation by one transfection or repeated transfections (following medium change) of the VEGF-A modRNA compared to the use of VEGF-A protein 3 or 7 days post treatment.
Transfection Mixture, supplied by Jackson Laboratory, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/transfection mixture/product/Jackson Laboratory
Average 90 stars, based on 1 article reviews
transfection mixture - by Bioz Stars, 2026-05
90/100 stars
  Buy from Supplier
co-transfection mixtures  (Promega)
90
Promega co-transfection mixtures
Endothelial differentiation of the human Isl1 + progenitors can be achieved by repeated transfections of the VEGF-A modRNA. (A) FACS result showing expression of mCherry in the day-7 purified human Isl1-cre eGFP + cells 24 h post <t>transfection</t> of the mCherry modRNA (1 μg/10 6 cells). (B) Quantification of mCherry expression by FACS showing percentage of mCherry + Isl1-cre eGFP + cells following 0-150 h post transfection. (C) ELISA analyses using VEGF-A-containing supernatant (refreshed 6 h before collection) cultured with the day-7 purified human Isl1-cre eGFP + cells following 0-72 h post transfection of different concentrations of the VEGF-A modRNA. (D) Trypan blue staining showing the survival percentage of the day-7 purified human Isl1-cre eGFP + cells following 24 h post transfection of different concentrations of the VEGF-A modRNA. (E) ELISA analyses showing the rate of VEGF-A secreted by the day-7 purified human Isl1-cre eGFP + cells (supernatant refreshed 6 h before collection) following two rounds of daily transfections of 1 μg/10 6 cells with VEGF-A modRNA. (F) FACS analyses showing the efficiency of CD144 + CD31 + EC differentiation by one transfection or repeated transfections (following medium change) of the VEGF-A modRNA compared to the use of VEGF-A protein 3 or 7 days post treatment.
Co Transfection Mixtures, supplied by Promega, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/co-transfection mixtures/product/Promega
Average 90 stars, based on 1 article reviews
co-transfection mixtures - by Bioz Stars, 2026-05
90/100 stars
  Buy from Supplier
transfection reagent mixture containing 20 pmol of scrambled sirna and of lipogene 2000 star  (Lipogene Company Inc)
90
Lipogene Company Inc transfection reagent mixture containing 20 pmol of scrambled sirna and of lipogene 2000 star
Endothelial differentiation of the human Isl1 + progenitors can be achieved by repeated transfections of the VEGF-A modRNA. (A) FACS result showing expression of mCherry in the day-7 purified human Isl1-cre eGFP + cells 24 h post <t>transfection</t> of the mCherry modRNA (1 μg/10 6 cells). (B) Quantification of mCherry expression by FACS showing percentage of mCherry + Isl1-cre eGFP + cells following 0-150 h post transfection. (C) ELISA analyses using VEGF-A-containing supernatant (refreshed 6 h before collection) cultured with the day-7 purified human Isl1-cre eGFP + cells following 0-72 h post transfection of different concentrations of the VEGF-A modRNA. (D) Trypan blue staining showing the survival percentage of the day-7 purified human Isl1-cre eGFP + cells following 24 h post transfection of different concentrations of the VEGF-A modRNA. (E) ELISA analyses showing the rate of VEGF-A secreted by the day-7 purified human Isl1-cre eGFP + cells (supernatant refreshed 6 h before collection) following two rounds of daily transfections of 1 μg/10 6 cells with VEGF-A modRNA. (F) FACS analyses showing the efficiency of CD144 + CD31 + EC differentiation by one transfection or repeated transfections (following medium change) of the VEGF-A modRNA compared to the use of VEGF-A protein 3 or 7 days post treatment.
Transfection Reagent Mixture Containing 20 Pmol Of Scrambled Sirna And Of Lipogene 2000 Star, supplied by Lipogene Company Inc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/transfection reagent mixture containing 20 pmol of scrambled sirna and of lipogene 2000 star/product/Lipogene Company Inc
Average 90 stars, based on 1 article reviews
transfection reagent mixture containing 20 pmol of scrambled sirna and of lipogene 2000 star - by Bioz Stars, 2026-05
90/100 stars
  Buy from Supplier
transfection master mixture  (Amaxa)
90
Amaxa transfection master mixture
Endothelial differentiation of the human Isl1 + progenitors can be achieved by repeated transfections of the VEGF-A modRNA. (A) FACS result showing expression of mCherry in the day-7 purified human Isl1-cre eGFP + cells 24 h post <t>transfection</t> of the mCherry modRNA (1 μg/10 6 cells). (B) Quantification of mCherry expression by FACS showing percentage of mCherry + Isl1-cre eGFP + cells following 0-150 h post transfection. (C) ELISA analyses using VEGF-A-containing supernatant (refreshed 6 h before collection) cultured with the day-7 purified human Isl1-cre eGFP + cells following 0-72 h post transfection of different concentrations of the VEGF-A modRNA. (D) Trypan blue staining showing the survival percentage of the day-7 purified human Isl1-cre eGFP + cells following 24 h post transfection of different concentrations of the VEGF-A modRNA. (E) ELISA analyses showing the rate of VEGF-A secreted by the day-7 purified human Isl1-cre eGFP + cells (supernatant refreshed 6 h before collection) following two rounds of daily transfections of 1 μg/10 6 cells with VEGF-A modRNA. (F) FACS analyses showing the efficiency of CD144 + CD31 + EC differentiation by one transfection or repeated transfections (following medium change) of the VEGF-A modRNA compared to the use of VEGF-A protein 3 or 7 days post treatment.
Transfection Master Mixture, supplied by Amaxa, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/transfection master mixture/product/Amaxa
Average 90 stars, based on 1 article reviews
transfection master mixture - by Bioz Stars, 2026-05
90/100 stars
  Buy from Supplier
transfection mixture  (SignaGen)
90
SignaGen transfection mixture
Endothelial differentiation of the human Isl1 + progenitors can be achieved by repeated transfections of the VEGF-A modRNA. (A) FACS result showing expression of mCherry in the day-7 purified human Isl1-cre eGFP + cells 24 h post <t>transfection</t> of the mCherry modRNA (1 μg/10 6 cells). (B) Quantification of mCherry expression by FACS showing percentage of mCherry + Isl1-cre eGFP + cells following 0-150 h post transfection. (C) ELISA analyses using VEGF-A-containing supernatant (refreshed 6 h before collection) cultured with the day-7 purified human Isl1-cre eGFP + cells following 0-72 h post transfection of different concentrations of the VEGF-A modRNA. (D) Trypan blue staining showing the survival percentage of the day-7 purified human Isl1-cre eGFP + cells following 24 h post transfection of different concentrations of the VEGF-A modRNA. (E) ELISA analyses showing the rate of VEGF-A secreted by the day-7 purified human Isl1-cre eGFP + cells (supernatant refreshed 6 h before collection) following two rounds of daily transfections of 1 μg/10 6 cells with VEGF-A modRNA. (F) FACS analyses showing the efficiency of CD144 + CD31 + EC differentiation by one transfection or repeated transfections (following medium change) of the VEGF-A modRNA compared to the use of VEGF-A protein 3 or 7 days post treatment.
Transfection Mixture, supplied by SignaGen, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/transfection mixture/product/SignaGen
Average 90 stars, based on 1 article reviews
transfection mixture - by Bioz Stars, 2026-05
90/100 stars
  Buy from Supplier
shrna knockdown jetpei transfection mixtures  (Avantor)
90
Avantor shrna knockdown jetpei transfection mixtures
Endothelial differentiation of the human Isl1 + progenitors can be achieved by repeated transfections of the VEGF-A modRNA. (A) FACS result showing expression of mCherry in the day-7 purified human Isl1-cre eGFP + cells 24 h post <t>transfection</t> of the mCherry modRNA (1 μg/10 6 cells). (B) Quantification of mCherry expression by FACS showing percentage of mCherry + Isl1-cre eGFP + cells following 0-150 h post transfection. (C) ELISA analyses using VEGF-A-containing supernatant (refreshed 6 h before collection) cultured with the day-7 purified human Isl1-cre eGFP + cells following 0-72 h post transfection of different concentrations of the VEGF-A modRNA. (D) Trypan blue staining showing the survival percentage of the day-7 purified human Isl1-cre eGFP + cells following 24 h post transfection of different concentrations of the VEGF-A modRNA. (E) ELISA analyses showing the rate of VEGF-A secreted by the day-7 purified human Isl1-cre eGFP + cells (supernatant refreshed 6 h before collection) following two rounds of daily transfections of 1 μg/10 6 cells with VEGF-A modRNA. (F) FACS analyses showing the efficiency of CD144 + CD31 + EC differentiation by one transfection or repeated transfections (following medium change) of the VEGF-A modRNA compared to the use of VEGF-A protein 3 or 7 days post treatment.
Shrna Knockdown Jetpei Transfection Mixtures, supplied by Avantor, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/shrna knockdown jetpei transfection mixtures/product/Avantor
Average 90 stars, based on 1 article reviews
shrna knockdown jetpei transfection mixtures - by Bioz Stars, 2026-05
90/100 stars
  Buy from Supplier
transfection mixture polyjet  (SignaGen)
90
SignaGen transfection mixture polyjet
Endothelial differentiation of the human Isl1 + progenitors can be achieved by repeated transfections of the VEGF-A modRNA. (A) FACS result showing expression of mCherry in the day-7 purified human Isl1-cre eGFP + cells 24 h post <t>transfection</t> of the mCherry modRNA (1 μg/10 6 cells). (B) Quantification of mCherry expression by FACS showing percentage of mCherry + Isl1-cre eGFP + cells following 0-150 h post transfection. (C) ELISA analyses using VEGF-A-containing supernatant (refreshed 6 h before collection) cultured with the day-7 purified human Isl1-cre eGFP + cells following 0-72 h post transfection of different concentrations of the VEGF-A modRNA. (D) Trypan blue staining showing the survival percentage of the day-7 purified human Isl1-cre eGFP + cells following 24 h post transfection of different concentrations of the VEGF-A modRNA. (E) ELISA analyses showing the rate of VEGF-A secreted by the day-7 purified human Isl1-cre eGFP + cells (supernatant refreshed 6 h before collection) following two rounds of daily transfections of 1 μg/10 6 cells with VEGF-A modRNA. (F) FACS analyses showing the efficiency of CD144 + CD31 + EC differentiation by one transfection or repeated transfections (following medium change) of the VEGF-A modRNA compared to the use of VEGF-A protein 3 or 7 days post treatment.
Transfection Mixture Polyjet, supplied by SignaGen, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/transfection mixture polyjet/product/SignaGen
Average 90 stars, based on 1 article reviews
transfection mixture polyjet - by Bioz Stars, 2026-05
90/100 stars
  Buy from Supplier
transfection reagent mixture  (Bellco Glass)
90
Bellco Glass transfection reagent mixture
Endothelial differentiation of the human Isl1 + progenitors can be achieved by repeated transfections of the VEGF-A modRNA. (A) FACS result showing expression of mCherry in the day-7 purified human Isl1-cre eGFP + cells 24 h post <t>transfection</t> of the mCherry modRNA (1 μg/10 6 cells). (B) Quantification of mCherry expression by FACS showing percentage of mCherry + Isl1-cre eGFP + cells following 0-150 h post transfection. (C) ELISA analyses using VEGF-A-containing supernatant (refreshed 6 h before collection) cultured with the day-7 purified human Isl1-cre eGFP + cells following 0-72 h post transfection of different concentrations of the VEGF-A modRNA. (D) Trypan blue staining showing the survival percentage of the day-7 purified human Isl1-cre eGFP + cells following 24 h post transfection of different concentrations of the VEGF-A modRNA. (E) ELISA analyses showing the rate of VEGF-A secreted by the day-7 purified human Isl1-cre eGFP + cells (supernatant refreshed 6 h before collection) following two rounds of daily transfections of 1 μg/10 6 cells with VEGF-A modRNA. (F) FACS analyses showing the efficiency of CD144 + CD31 + EC differentiation by one transfection or repeated transfections (following medium change) of the VEGF-A modRNA compared to the use of VEGF-A protein 3 or 7 days post treatment.
Transfection Reagent Mixture, supplied by Bellco Glass, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/transfection reagent mixture/product/Bellco Glass
Average 90 stars, based on 1 article reviews
transfection reagent mixture - by Bioz Stars, 2026-05
90/100 stars
  Buy from Supplier

Image Search Results


Endothelial differentiation of the human Isl1 + progenitors can be achieved by repeated transfections of the VEGF-A modRNA. (A) FACS result showing expression of mCherry in the day-7 purified human Isl1-cre eGFP + cells 24 h post transfection of the mCherry modRNA (1 μg/10 6 cells). (B) Quantification of mCherry expression by FACS showing percentage of mCherry + Isl1-cre eGFP + cells following 0-150 h post transfection. (C) ELISA analyses using VEGF-A-containing supernatant (refreshed 6 h before collection) cultured with the day-7 purified human Isl1-cre eGFP + cells following 0-72 h post transfection of different concentrations of the VEGF-A modRNA. (D) Trypan blue staining showing the survival percentage of the day-7 purified human Isl1-cre eGFP + cells following 24 h post transfection of different concentrations of the VEGF-A modRNA. (E) ELISA analyses showing the rate of VEGF-A secreted by the day-7 purified human Isl1-cre eGFP + cells (supernatant refreshed 6 h before collection) following two rounds of daily transfections of 1 μg/10 6 cells with VEGF-A modRNA. (F) FACS analyses showing the efficiency of CD144 + CD31 + EC differentiation by one transfection or repeated transfections (following medium change) of the VEGF-A modRNA compared to the use of VEGF-A protein 3 or 7 days post treatment.

Journal: Cell Research

Article Title: Driving vascular endothelial cell fate of human multipotent Isl1 + heart progenitors with VEGF modified mRNA

doi: 10.1038/cr.2013.112

Figure Lengend Snippet: Endothelial differentiation of the human Isl1 + progenitors can be achieved by repeated transfections of the VEGF-A modRNA. (A) FACS result showing expression of mCherry in the day-7 purified human Isl1-cre eGFP + cells 24 h post transfection of the mCherry modRNA (1 μg/10 6 cells). (B) Quantification of mCherry expression by FACS showing percentage of mCherry + Isl1-cre eGFP + cells following 0-150 h post transfection. (C) ELISA analyses using VEGF-A-containing supernatant (refreshed 6 h before collection) cultured with the day-7 purified human Isl1-cre eGFP + cells following 0-72 h post transfection of different concentrations of the VEGF-A modRNA. (D) Trypan blue staining showing the survival percentage of the day-7 purified human Isl1-cre eGFP + cells following 24 h post transfection of different concentrations of the VEGF-A modRNA. (E) ELISA analyses showing the rate of VEGF-A secreted by the day-7 purified human Isl1-cre eGFP + cells (supernatant refreshed 6 h before collection) following two rounds of daily transfections of 1 μg/10 6 cells with VEGF-A modRNA. (F) FACS analyses showing the efficiency of CD144 + CD31 + EC differentiation by one transfection or repeated transfections (following medium change) of the VEGF-A modRNA compared to the use of VEGF-A protein 3 or 7 days post treatment.

Article Snippet: In vivo transfection was performed by adding the transfection mixture (5 μg modRNA) directly into the cell-containing matrigel before s.c. implantation into NOD/SCID mice (Jackson lab).

Techniques: Transfection, Expressing, Purification, Enzyme-linked Immunosorbent Assay, Cell Culture, Staining